Page last updated: 2024-08-24

aripiprazole and amitriptyline

aripiprazole has been researched along with amitriptyline in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Sen, S; Sinha, N1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Altamura, C; Arzuaga, A; Ciranna, L; Costa, L; Desaphy, JF; Lacivita, E; Leopoldo, M; Niso, M; Ragozzino, ME; Stama, ML1
Choudhary, PP; Munda, S; Pattojoshi, A; Prakash, R1
Motomura, H; Takenoshita, M; Toyofuku, A1
Arnold, LE; Han, JC; Hellings, JA1

Reviews

2 review(s) available for aripiprazole and amitriptyline

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
    Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:6

    Topics: Adolescent; Adult; Amitriptyline; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Brain-Derived Neurotrophic Factor; Child; Dopamine Antagonists; Humans; Irritable Mood; Loxapine; Risperidone

2017

Other Studies

6 other study(ies) available for aripiprazole and amitriptyline

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Privileged scaffold-based design to identify a novel drug-like 5-HT
    European journal of medicinal chemistry, 2020, Aug-01, Volume: 199

    Topics: Dose-Response Relationship, Drug; Drug Design; Fragile X Syndrome; HEK293 Cells; Humans; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship

2020
Benign clinical picture after ingestion of 780 milligrams of aripiprazole and 1050 milligrams of amitriptyline.
    Indian journal of medical sciences, 2009, Volume: 63, Issue:2

    Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Drug Overdose; Humans; Male; Piperazines; Quinolones; Suicide, Attempted

2009
Low-Dose Aripiprazole Augmentation in Amitriptyline-Resistant Burning Mouth Syndrome: Results from Two Cases.
    Pain medicine (Malden, Mass.), 2017, 04-01, Volume: 18, Issue:4

    Topics: Aged; Amitriptyline; Analgesics, Non-Narcotic; Antipsychotic Agents; Aripiprazole; Burning Mouth Syndrome; Drug Therapy, Combination; Female; Humans; Middle Aged

2017